OSE Immunotherapeutics SA(GB:0RAD)
€1.80+0.09 (+5.57%)
GB:0RAD
OSE Immunotherapeutics SA financials statements
€1.80
At close:+0.09 (+5.57%)
OSE Immunotherapeutics SA (0RAD) Income Statement
2 Followers
OSE Immunotherapeutics SA Income Statement
Last quarter (Q4 2025), OSE Immunotherapeutics SA's total revenue was €1.30M, an increase of 49.14% from the same quarter last year. In Q4, OSE Immunotherapeutics SA's net income was €-22.59M. See OSE Immunotherapeutics SA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 2.62M | € 69.88M | € 2.23M | € 18.30M | € 26.31M | |
| € 2.62M | € 69.88M | € 2.23M | € 18.30M | € 26.31M | |
| € 39.19M | € 41.52M | € 25.21M | € 36.78M | € 42.93M | |
| Depreciation and Amortization | € 3.25M | € 3.31M | € 3.52M | € 3.54M | € 2.66M |
| € -44.81M | € 41.14M | € -17.50M | € -13.11M | € -13.72M | |
| € -48.06M | € 43.73M | € -22.99M | € -18.48M | € -16.63M | |
| € 6.00M | € -3.90M | € -235.00K | € 454.00K | € -588.00K | |
| € -42.05M | € 39.83M | € -23.22M | € -23.45M | € -21.56M | |
| € -37.70M | € 37.45M | € -23.00M | € -17.76M | € -16.85M | |
| Per Share Metrics | |||||
| Basic EPS | € -1.69 | € 1.72 | € -1.18 | € -0.96 | € -0.93 |
| Diluted EPS | € -1.69 | € 1.72 | € -1.18 | € -0.96 | € -0.93 |
| Weighted Average Shares Outstanding | 22.31M | 21.81M | 19.56M | 18.46M | 18.16M |
| Weighted Average Shares Outstanding (Diluted) | 22.31M | 21.81M | 19.56M | 18.46M | 18.16M |
Currency in EUR
